Index no

Topic Name

Page Number

1

HOST FACTORS IN INFECTION AND IMMUNE RESPONSE

4

2

INFECTIONS IN POST-SPLENECTOMY PATIENTS

8

3

ADULT IMMUNIZATION

11

4

HEALTH ASPECTS OF INTERNATIONAL TRAVEL

14

5

HEAT STROKE

18

6

HOSPITAL-ACQUIRED PNEUMONIA (HAP)

21

7

ATYPICAL PNEUMONIAS

24

8

VENTILATOR ASSOCIATED PNEUMONIA

28

9

CAVITARY PNEUMONIA

32

10

LUNG ABSCESS

36

11

CELLULITIS AND NECROTIZING FASCIITIS

40

12

NECROTIZING FASCIITIS

42

13

OSTEOMYELITIS

45

14

TRAVELER’S DIARRHEA

49

15

CLOSTRIDIUM DIFFICILE INFECTION (CDI)

53

16

CATHETER-ASSOCIATED URINARY TRACT INFECTIONS (CAUTI)

58

17

RECURRENT URINARY TRACT INFECTION (UTI)

62

18

ASYMPTOMATIC BACTERIURIA

66

19

COMPLICATED URINARY TRACT INFECTIONS (UTIS)

69

20

PYELONEPHRITIS

74

21

EMPHYSEMATOUS AND XANTHOGRANULOMATOUS PYELONEPHRITIS

79

22

XANTHOGRANULOMATOUS PYELONEPHRITIS (XGP)

81

23

GENITAL ULCERS

83

24

ENCEPHALITIS

87

25

ACUTE MENINGITIS

90

26

CHRONIC MENINGITIS

93

27

BRAIN ABSCESS

97

28

POST-EXPOSURE PROPHYLAXIS (PEP)

101

29

POST-TRANSPLANT INFECTIONS

104

30

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)

108

31

TETANUS

112

32

BOTULISM

115

33

MENINGOCOCCAL MENINGITIS

118

34

LEGIONELLA INFECTION

121

35

TYPHOID FEVER

124

36

TUBERCULOSIS

128

37

Treatment Regimens and Guidelines for MDR-TB and XDR-TB

133

38

LATENT TUBERCULOSIS (LATENT TB)

136

39

LEPROSY

141

40

LEPRA REACTIONS

145

41

INTERFERONS

148

42

INFECTIOUS MONONUCLEOSIS

151

43

CYTOMEGALOVIRUS (CMV) INFECTIONS

155

44

HEMORRHAGIC FEVER SYNDROMES

159

45

SCRUB TYPHUS

163

46

DENGUE FEVER

167

47

DENGUE SHOCK SYNDROME (DSS)

172

48

ANTIMICROBIAL RESISTANCE (AMR)

176

49

ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP)

180

50

CHIKUNGUNYA FEVER

184

51

RISK STRATIFICATION AND MANAGEMENT OF A CASE OF DOG BITE

188

52

RABIES POST-EXPOSURE PROPHYLAXIS (PEP)

192

53

HIV

195

54

NEUROLOGICAL AND CARDIAC MANIFESTATIONS OF HIV

201

55

PULMONARY AND GASTROINTESTINAL MANIFESTATIONS OF HIV

204

56

ONCOLOGICAL AND RHEUMATOLOGICAL MANIFESTATIONS OF HIV

208

57

OPPORTUNISTIC INFECTIONS IN HIV

211

58

MANAGEMENT OF HIV

215

59

POST-EXPOSURE PROPHYLAXIS (PEP) FOR HIV

219

60

HIV Drug Resistance and HIV Vaccination

222

61

PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV

225

62

IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME

228

63

LEPTOSPIROSIS

232

64

HERPES SIMPLEX VIRUS (HSV)

236

65

HERPES ZOSTER

239

66

FILARIASIS

243

67

TOXOPLASMOSIS

246

68

KALA AZAR (VISCERAL LEISHMANIASIS)

250

69

DERMAL LEISHMANIASIS

255

70

AMEBIASIS

259

71

MALARIA

263

72

PARASITIC INFESTATIONS OF THE CENTRAL NERVOUS SYSTEM (CNS)

274

73

PNEUMOCYSTIS JIROVECII PNEUMONIA (PJP)

276

74

MUCORMYCOSIS

280

75

ASPERGILLOSIS

284

76

CANDIDIASIS

289

77

CRYPTOCOCCAL MENINGITIS

294

78

Assessment and Management of Pustular Rash

299

79

Avian Influenza A (H5N1) Virus Infection

301

80

Acute Pharyngitis

303

81

Anorectal Abscess

306

82

Acute Diarrhoea

308

83

Postoperative Fever

311

84

Acute Bronchitis

313

85

Animal Bites

316

86

Aspiration Pneumonia

319

87

Maculopapular Rash

322

88

Vesicular-Bullous Rash

325

89

Acute Aspiration

328

90

Chancroid

331

91

Clostridioides difficile-Associated Disease (CDAD)

334

92

Dermatophyte Infections

337

93

Chagas Disease

340

94

Cholera

343

95

Diphtheria

345

96

SYPHILIS

347

97

INFECTIVE ENDOCARDITIS

352

98

ORAL ANTIBIOTICS IN IE

366